Publications by authors named "J Stoker"
Background And Objective: Current guidelines on radiological follow-up (FU) for patients after treatment for nonmetastatic renal cell carcinoma (RCC) are not based on robust evidence. This review aims to evaluate whether the 2022 European Association of Urology (EAU) guidelines are noninferior, in terms of recurrence and (overall) survival, to a higher imaging frequency of computed tomography (CT) of the chest and abdomen.
Methods: A literature search of relevant search machines (PubMed/Medline and EMBASE) was performed up to May 29, 2024.
Introduction: Hysterosalpingography (HSG) and hysterosalpingo-foam sonography (HyFoSy) are commonly used tubal patency tests during the fertility work-up. Besides its diagnostic purpose, HSG with oil-based contrast can also be applied for its fertility-enhancing effect, by tubal flushing. HyFoSy is considered as less painful compared with HSG, it lacks exposure to iodinated contrast medium and ionising radiation.
View Article and Find Full Text PDFObjectives: Total tumor volume (TTV) is associated with overall and recurrence-free survival in patients with colorectal cancer liver metastases (CRLM). However, the labor-intensive nature of such manual assessments has hampered the clinical adoption of TTV as an imaging biomarker. This study aimed to develop and externally evaluate a CRLM auto-segmentation model on CT scans, to facilitate the clinical adoption of TTV.
View Article and Find Full Text PDFArticle Synopsis
- The study assesses the effectiveness of an AI algorithm for detecting pulmonary nodules using ultra-low-dose CT scans in emergency departments, highlighting its role in improving diagnosis.
- A total of 870 patients were included, with the AI identifying 104 true positives but also generating 1,758 false positives, indicating a high trade-off between missed nodules and unnecessary alerts.
- The conclusion emphasizes that while AI significantly increases the detection of potentially harmful nodules (5.8 times more), it also raises the rate of false positives (42.9 times more), which can lead to additional unneeded follow-ups.